NCT03464032View on ClinicalTrials.gov

A Study of BCD-135 in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

October 31, 2018

Conditions

MelanomaNSCLCRenal Cell CarcinomaBladder Cancer

Interventions

DRUG

BCD-135

Monoclonal anti-PD-L1 antibody

Trial Locations (1)

Unknown

RECRUITING

LLC BioEk, Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biocad

INDUSTRY